Quest Diagnostics Incorporated
DGX
$175.16
$1.400.81%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.90% | -1.77% | -1.31% | 18.04% | 1.04% |
| Total Depreciation and Amortization | 3.70% | 8.00% | 6.84% | 0.86% | 6.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.54% | 57.45% | 135.00% | -33.33% | -42.31% |
| Change in Net Operating Assets | -372.73% | 178.57% | -600.00% | 96.77% | -206.90% |
| Cash from Operations | -32.33% | 30.34% | -1.11% | 133.77% | -70.78% |
| Capital Expenditure | 4.88% | -16.04% | -15.22% | 11.54% | -44.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 75.02% | -1,346.23% | 25.35% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00% | -33.33% | 400.00% | -106.06% | 178.57% |
| Cash from Investing | 77.09% | 69.26% | -716.50% | 6.10% | -86.84% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -59,900.00% | 0.00% | 99.67% | -- | -- |
| Issuance of Common Stock | 38.10% | -12.50% | 50.00% | 33.33% | 0.00% |
| Repurchase of Common Stock | 72.19% | -15,000.00% | -- | 100.00% | 91.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | 0.00% | -6.33% | 1.25% |
| Other Financing Activities | -275.56% | 421.43% | -333.33% | 109.52% | -3,250.00% |
| Cash from Financing | -230.00% | -109.60% | 587.60% | -137.25% | -217.69% |
| Foreign Exchange rate Adjustments | 114.29% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.91% | -143.61% | 342.86% | 4.25% | -139.04% |